ProtoKinetix, Incorporated (OTCMKTS:PKTX) Short Interest Update

ProtoKinetix, Incorporated (OTCMKTS:PKTX) was the target of a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 10,000 shares, a growth of 40.8% from the January 15th total of 7,100 shares. Based on an average daily trading volume, of 347,300 shares, the short-interest ratio is presently 0.0 days.

ProtoKinetix Price Performance

Shares of PKTX traded up $0.00 during mid-day trading on Friday, hitting $0.01. 949,666 shares of the company’s stock were exchanged, compared to its average volume of 168,530. ProtoKinetix has a fifty-two week low of $0.01 and a fifty-two week high of $0.02. The business’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01.

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.